相关实验视频
Updated: Jul 21, 2025

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
肝细胞癌中的ROS:我们所知道的
Lin Xing1, Yuting Tang1, Lu Li2
1Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China; School of Pharmacy, Dalian Medical University, Dalian, 116044, China.
肝细胞癌 (HCC) 治疗面临着药物耐药性的挑战. 本综述探讨了针对晚期肝癌的活性氧物种 (ROS) 的新型实验性疗法.
科学领域:
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是一种具有不良预后的原发性肝癌,通常在晚期被诊断出来.
- 系统疗法是高级HCC的主要治疗方法,但药物耐药性是一个重大挑战.
- 反应性氧物种 (ROS) 在癌症中起着双重作用,作为标记物和治疗点.
研究的目的:
- 审查用于肝细胞癌 (HCC) 治疗的新兴实验药物.
- 专注于针对HCC的新型疗法,以反应性氧物种 (ROS) 为点.
- 提供对晚期肝癌新疗法途径的见解.
主要方法:
- 对HCC的实验药物的文献综述.
- 基于输送系统和向机制对药物的分类.
- 分析反应性氧物种 (ROS) 在HCC病原和治疗中的作用.
主要成果:
- 几种类型的实验药物显示出对HCC治疗的前景.
- 目前正在研究纳米载体,外体,抗体,体和多糖类药物.
- 有针对性的ROS调节提供了一个潜在的策略,以克服HCC的耐药性.
结论:
- 针对ROS的试验性药物为高级HCK患者提供了新的希望.
- 新型药物输送系统对于有效的HCC治疗至关重要.
- 需要进一步的研究才能将这些实验性疗法转化为临床实践.
更多相关视频
05:16Author Spotlight: High-Throughput Measurement of Intracellular ROS Levels in Hepatocellular Lines
Published on: January 19, 2024
14:25Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
Published on: May 13, 2022
相关概念视频
Peroxisomes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Radical Autoxidation
Oxygen Requirements and Growth Patterns